Table 1 Information of samples used in the study
From: Tau exhibits unique seeding properties in globular glial tauopathy
Sample | PathDx | Age at death | Sex | Braak NFT Stage | MAPT mutation | GGT subtype |
|---|---|---|---|---|---|---|
Control 1 | Normal | 63 | M | III | Â | Â |
Control 2 | Normal | 81 | M | II | Â | Â |
AD 1 | AD | 68 | M | VI | Â | Â |
AD 2 | AD | 72 | F | V-VI | Â | Â |
AD 3 | AD | 81 | F | VI | Â | Â |
AD 4 | AD | 91 | F | VI | Â | Â |
PSP 1 | PSP | 59 | M | II | Â | Â |
PSP 2 | PSP | 66 | M | II | Â | Â |
CBD 1 | CBD | 67 | M | II | Â | Â |
CBD 2 | CBD | 69 | M | II | Â | Â |
GGT1 | GGT | 82 | M | 0-I | Â | GGT subtype I |
GGT2 | GGT | 55 | F | V | Â | GGT subtype III |
GGT3 | GGT | 69 | M | II | Â | GGT subtype III |
GGT4 | GGT | 68 | F | III | Â | GGT subtype II |
GGT5 | GGT | 69 | F | II-II | MAPT K317 N | GGT subtype III |